SQSTM1 and acute myeloid leukemia: Similar to in vitro experiments, birinapant elevated the LC3‐II level, accompanied by the down‐regulation of SQSTM1/p62 in tumour tissues in the birinapant treatment group (Figure 6D and Figure S6), indicating that autophagy does occur in the birinapant‐treated AML cells.